Moreover, other antitumor effects via AMPK, analyzed firstly in cultured HCC cells, were also demonstrated in HCC cell-xenotransplantated mice treated with metformin at pharmacological doses4,29, this supporting further translational hypotheses and clinical studies with metformin in HCC patients from in vitro evidence. The gene discussed is PRKAA1; the disease is hepatocellular carcinoma.